PRNB insider filings
Principia Biopharma Inc. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-09-28. Screen PRNB transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for PRNB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Principia Biopharma Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2020-09-28 | 4 | Tomasello Shawn — Director | Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) | EDGAR |
| 2020-09-28 | 4 | George Simeon — Director | Code (U): 2,982,855 @ $100 · Disposition to issuer (D): 28,623 (derivative) · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative) | EDGAR |
| 2020-09-28 | 4 | Lin Shao-Lee — Director | Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative) | EDGAR |
| 2020-09-28 | 4 | Becker Daniel J. — Director | Code (U): 667,600 @ $100 · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative) | EDGAR |
| 2020-09-28 | 4 | Wolff Stefani — Chief Development Officer | Gift (G): 5,504 @ $0 · Code (U): 13,592 @ $100 · Disposition to issuer (D): 30,056 (derivative) · Disposition to issuer (D): 16,843 (derivative) · Disposition to issuer (D): 22,017 (derivative) · Disposition to issuer (D): 55,042 (derivative) · +2 more | EDGAR |
| 2020-09-28 | 4 | Thomas Dolca — Chief Medical Officer | Code (U): 2,207 @ $100 · Disposition to issuer (D): 168,057 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 55,000 (derivative) | EDGAR |
| 2020-09-28 | 4 | Goldstein David M — Chief Scientific Officer | Code (U): 31,826 @ $100 · Disposition to issuer (D): 12,960 (derivative) · Disposition to issuer (D): 13,210 (derivative) · Disposition to issuer (D): 8,807 (derivative) · Disposition to issuer (D): 15,412 (derivative) · Disposition to issuer (D): 22,017 (derivative) · +4 more | EDGAR |
| 2020-09-28 | 4 | Hardiman Roy C. — Chief Business Officer | Code (U): 117,761 @ $100 · Code (U): 1,916 @ $100 · Disposition to issuer (D): 11,519 (derivative) · Disposition to issuer (D): 44,034 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 55,000 (derivative) | EDGAR |
| 2020-09-28 | 4 | Babler Martin — President, CEO, Director | Code (U): 1,023 @ $100 · Code (U): 39,179 @ $100 · Code (U): 18,355 @ $100 · Disposition to issuer (D): 255 (derivative) · Disposition to issuer (D): 50,795 (derivative) · Disposition to issuer (D): 85,728 (derivative) · +7 more | EDGAR |
| 2020-09-28 | 4 | CHAI CHRISTOPHER Y — Chief Financial Officer | Code (U): 3,799 @ $100 · Code (U): 3,302 @ $100 · Disposition to issuer (D): 56,982 (derivative) · Disposition to issuer (D): 24,769 (derivative) · Disposition to issuer (D): 29,723 (derivative) · Disposition to issuer (D): 13,210 (derivative) · +4 more | EDGAR |
| 2020-09-28 | 4 | Colowick Alan — Director | Disposition to issuer (D): 47,724 (derivative) · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative) | EDGAR |
| 2020-09-28 | 4 | Machado Patrick — Director | Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative) | EDGAR |
| 2020-09-22 | 4 | Hardiman Roy C. — Chief Business Officer | Option exercise (M): 2,758 @ $4.72 · Option exercise (M): 2,242 @ $7.27 · Sale (S): 5,000 @ $99.98 · Option exercise (M): 2,758 (derivative) @ $0 · Option exercise (M): 2,242 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | Thomas Dolca — Chief Medical Officer | Option exercise (M): 15,000 @ $23.77 · Sale (S): 15,000 @ $100 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | CHAI CHRISTOPHER Y — Chief Financial Officer | Option exercise (M): 7,500 @ $3.00 · Sale (S): 7,500 @ $99.37 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2020-08-20 | 4 | BVF PARTNERS L P/IL — 10% owner BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Purchase (P): 1,205 (derivative) @ $35.79 · Purchase (P): 905 (derivative) @ $35.79 · Purchase (P): 158 (derivative) @ $35.79 | EDGAR |
| 2020-08-12 | 4 | Goldstein David M — Chief Scientific Officer | Option exercise (M): 2,447 @ $3.00 · Option exercise (M): 3,553 @ $3.18 · Sale (S): 858 @ $86.11 · Sale (S): 700 @ $86.92 · Sale (S): 2,534 @ $88.40 · Sale (S): 700 @ $89.68 · +4 more | EDGAR |
Recent 8-K events — Principia Biopharma Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2020-09-28 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2020-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PRNB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs